EFFICACY AND SAFETY OF TUMOUR NECROSIS FACTOR ALPHA INHIBITORS IN RHEUMATOID ARTHRITIS

被引：0
|
作者：
Baraza Cristina, Gomez [1 ]
Francisco Javier, Manero Ruiz [2 ]
Espasol Angela, Pecondon [2 ]
Mendoza Mercedes, Arenere [3 ]
Orbis Iciar, Casiamares [1 ]
Maria Jose, Rabanaque Hernandez [4 ]
机构：
[1] Hosp Univ Miguel Servet, Dept Pharm, Zaragoza, Spain
[2] Hosp Univ Miguel Servet, Rheumatol Serv, Zaragoza, Spain
[3] Hosp Clin Lozano Blesa, Dept Pharm, Zaragoza, Spain
[4] Univ Zaragoza, Fac Med, Dept Microbiol, Prevent Med & Publ Hlth, Zaragoza, Spain
来源：
ATENCION FARMACEUTICA | 2013年 / 15卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Objective: To evaluate the efficacy and safety of tumor necrosis factor alpha inhibitors in Rheumatoid Arthritis (RA). Method: An observational and retrospective study conducted on patients with RA treated at a hospital between May 2000 and December 2009. We analyzed the influence of demographic and clinical factors in the effectiveness of treatments and made a comparison between them. We determined the durability of the anti-TNF-alpha agents and adverse reactions. Results: The efficacy study showed improvement in the clinical variables. The survival analysis showed no significant differences depending on the used drug or treatment line. The safety analysis revealed risk of infections. Conclusion: Infliximab, etanercept, and adalimumab are effective drugs for RA therapy, improving symptoms control and showing similar effectiveness between them.
引用
收藏
页码：150 / 157
页数：8
相关论文
共 50 条
  • [31] Anti-tumour necrosis factor a therapy in rheumatoid arthritis: an update on safety
    Hyrich, KL
    Silman, AJ
    Watson, KD
    Symmons, DPM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1538 - 1543
  • [32] Effectiveness and safety of the treatment with tumour necrosis factor a antagonists in rheumatoid arthritis patients
    Mendoza, MA
    Aznárez, HN
    Hernández, MJR
    Ruiz, FJM
    [J]. MEDICINA CLINICA, 2005, 125 (01): : 35 - 36
  • [33] Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis
    Padyukov, L
    Lampa, J
    Heimbürger, M
    Ernestam, S
    Cederholm, T
    Lundkvist, I
    Andersson, P
    Hermansson, Y
    Harju, A
    Klareskog, L
    Bratt, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (06) : 526 - 529
  • [34] Comparison of the efficacy of the tumour necrosis factor alpha blocking agents etanercept and infliximab in patients with active rheumatoid arthritis
    De Filippis, LG
    Caliri, A
    Scibilia, G
    Miceli, G
    Romano, C
    Sangari, D
    Bartolone, S
    Lo Gullo, R
    Bagnato, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 411 - 411
  • [35] SAFETY AND EFFICACY OF OCRELIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE OR TUMOUR NECROSIS FACTOR INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ahmed, Hussien
    Abushouk, Abdelrahman Ibrahim
    Ismail, Ammar
    Elmaraezy, Ahmed
    Badr, Ahmed Said
    Gadelkarim, Mohamed
    Elnenny, Mohammed
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : A8 - A8
  • [36] Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood
    Heiligenhaus, A.
    Horneff, G.
    Greiner, K.
    Mackensen, F.
    Zierhut, M.
    Foeldvari, I.
    Michels, H.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2007, 224 (06) : 526 - 531
  • [37] Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors
    Ranganathan, Prabha
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (05) : E4 - E4
  • [38] New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
    Scott, David L.
    Cope, Andrew
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) : 767 - 769
  • [39] TUMOUR NECROSIS FACTOR INHIBITORS AND THE RISK OF ACUTE CORONARY SYNDROMES IN RHEUMATOID ARTHRITIS PATIENTS
    Ljung, L.
    Askling, J.
    Rantapaa-Dahlqvist, S.
    Jacobsson, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 244 - 244
  • [40] GENETIC INFLUENCE OF DIFFERENT MEASURE FOR TUMOUR NECROSIS FACTOR INHIBITORS RESPONSE IN RHEUMATOID ARTHRITIS
    Bang, S.
    Park, Y.
    Kim, K.
    Joo, Y. B.
    Cho, S. -K.
    Choi, C. -B.
    Sung, Y. -K.
    Kim, T. -H.
    Jun, J. -B.
    Yoo, D. -H.
    Lee, H. -S.
    Bae, S. -C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1211 - 1211
12345